26.46% percent quarterly performance for Ultragenyx Pharmaceutical Inc. (RARE) is not indicative of the underlying story
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) kicked off on Tuesday, up 1.77% from the previous trading day, before settling in for the closing price of $50.90.